Hemogenyx Pharmaceuticals Plc Stock Today
| HOPHF Stock | USD 0.04 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 70
|
Hemogenyx Pharmaceuticals is trading at 0.04 as of the 24th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.04. Hemogenyx Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Hemogenyx Pharmaceuticals Plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of July 2022 and ending today, the 24th of April 2024. Click here to learn more.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was founded in 2012 and is headquartered in London, the United Kingdom. The company has 1.14 B outstanding shares. More on Hemogenyx Pharmaceuticals Plc
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hemogenyx Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hemogenyx Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hemogenyx Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Hemogenyx Pharmaceuticals Plc [HOPHF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemogenyx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hemogenyx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hemogenyx Pharmaceuticals classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 1.14 B outstanding shares.
Hemogenyx Pharmaceuticals Plc has accumulated about 6.84 M in cash with (2.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Hemogenyx Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationHemogenyx Pharmaceuticals Plc has a total of 1.14 Billion outstanding shares. Hemogenyx Pharmaceuticals retains 13.01 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hemogenyx Ownership Details
Hemogenyx Stock Against Markets
Picking the right benchmark for Hemogenyx Pharmaceuticals pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Hemogenyx Pharmaceuticals pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Hemogenyx Pharmaceuticals is critical whether you are bullish or bearish towards Hemogenyx Pharmaceuticals Plc at a given time. Please also check how Hemogenyx Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hemogenyx Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Hemogenyx Pharmaceuticals Corporate Management
Elected by the shareholders, the Hemogenyx Pharmaceuticals' board of directors comprises two types of representatives: Hemogenyx Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hemogenyx. The board's role is to monitor Hemogenyx Pharmaceuticals' management team and ensure that shareholders' interests are well served. Hemogenyx Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hemogenyx Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Vladislav Sandler | CEO CoFounder | Profile | |
| Alexis JD | Independent Director | Profile | |
| Koen MD | Clinical Director | Profile | |
| Andrew Wright | Financial Sec | Profile |
How to buy Hemogenyx Pink Sheet?
Before investing in Hemogenyx Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Hemogenyx Pharmaceuticals. To buy Hemogenyx Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Hemogenyx Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Hemogenyx Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Hemogenyx Pharmaceuticals Plc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Hemogenyx Pharmaceuticals Plc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Hemogenyx Pharmaceuticals Plc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Hemogenyx Pharmaceuticals Plc?
The danger of trading Hemogenyx Pharmaceuticals Plc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Hemogenyx Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Hemogenyx Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Hemogenyx Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemogenyx Pharmaceuticals Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Hemogenyx Pharmaceuticals information on this page should be used as a complementary analysis to other Hemogenyx Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |